Strengthens drug development services and enhances capabilities to support increasing customer demand
October 8, 2024 2:29 PM EDT | Source: APG
ELKRIDGE, Maryland–(Newsfile Corp. – October 8, 2024) – Vici Health Sciences, a leading provider of pharmaceutical formulation, analytical and regulatory services, significantly expands its staff and physical footprint in Maryland. We are pleased to announce that. This expansion is in response to growing demand for the company’s comprehensive drug development services and will enable Vici Health Sciences to better serve its growing customer base.
vici health science
To view an expanded version of this graphic, please visit:
https://images.newsfilecorp.com/files/8798/226037_f01348ed843a98e2_001full.jpg
Investing in growth and innovation
This expansion includes the addition of a state-of-the-art facility in Elkridge, Maryland, with advanced technology to support enhanced formulation development, analytical testing, and clinical supply manufacturing capabilities. This strategic growth initiative also includes significant staff increases, adding highly skilled scientists, regulatory experts and technical experts to the team.
“Most early-stage innovation happens outside of the big pharma ecosystem,” said Dr. Anish Dhanarajan, CEO of Vici Health Sciences. “Pharmaceutical start-ups, small pharma companies, and clinical-stage companies tend to be virtual companies and lack the CMC expertise and equipment needed to successfully formulate and test new medicines. In many cases, this expansion also renews our commitment to providing full-service research and development, clinical batch manufacturing, and regulatory filing support to our smaller customers. It also increases our ability to support larger and more complex projects.”
Supporting a growing customer base
With expanded facilities and teams, Vici Health Sciences is poised to increase its capabilities in formulation development, analytical method development, and clinical trial material manufacturing. The company’s growth will enable faster project turnaround times, greater flexibility and better support for customers navigating the complexities of drug development and regulatory compliance.
Key highlights of the expansion include:
Enhanced formulation and manufacturing capabilities: The new facility will feature additional equipment and resources to support the manufacturing of advanced formulations and clinical supplies.
Increased analytical and testing capacity: Expanded laboratory space and state-of-the-art equipment will enable Vici Health Sciences to handle higher volume analytical testing projects.
Enhanced Regulatory Support: The growth of our team of regulatory experts will enable Vici to further streamline CMC documentation, regulatory filing, and compliance services for both small and large projects.
Built on a tradition of excellence
This expansion underscores Vici Health Sciences’ continued commitment to providing innovative, high-quality drug development services. With a focus on scientific excellence and customer satisfaction, Vici Health Sciences is well positioned to meet the needs of both new and existing customers in the rapidly evolving pharmaceutical industry.
About Vici Health Science
Vici Health Sciences is a trusted partner for pharmaceutical and biotechnology companies specializing in formulation development, analytical method development, manufacturing process development, regulatory compliance, and CMC consulting. With a focus on quality and innovation, Vici Health Sciences provides end-to-end solutions that support the entire drug development lifecycle, from early-stage research to commercialization.
For more information about Vici Health Sciences’ expansion and services, please visit vicihealthsciences.com or contact info@vicihealth.com or +1 410-379-1500.
Source: Vici Health Sciences
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226037.
Source:APG
